search
Back to results

Infant Formula With Partially Hydrolyzed Cow's Milk Protein Versus a Formula With Intact Protein (VEGY-UP)

Primary Purpose

Infant Colic

Status
Unknown status
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Partially hydrolyzed formula (pHF)
Standard formula (SF)
Sponsored by
Laboratorios Ordesa
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Infant Colic focused on measuring Infant formula, Partially hydrolized protein infant formula

Eligibility Criteria

2 Weeks - 8 Weeks (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Children diagnosed as nursing colic according to Roma IV criteria.
  • Infants who have received breastfeeding at least 2 weeks.
  • Infants who at the time of inclusion in the study whose parents/legal guardians voluntarily decide not to continue exclusive breastfeeding or only maintain it in residual form (less than 20% of the daily intake, one breast intake per day).
  • Full-term infants (>37 weeks of gestation).
  • Infants with weight suitable for their gestational age (2500-4500g).
  • Normal APGAR score: 7-10.
  • Infants between 2 and 8 weeks of life.
  • Infants whose parents/legal guardians have signed informed consent.
  • Infants with good availability of clinical follow-up until the end of the study.

Exclusion Criteria:

  • Infants fed from birth with exclusive infant formula.
  • Infants with congenital diseases or malformations that may affect growth.
  • Infants with major medical conditions that require chronic medication or close medical checks.
  • Infants who have taken any type of antibiotics or probiotics prior to the study.

Sites / Locations

  • Consorci Sanitari de TerrassaRecruiting
  • Fundació Hospital de Nens

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Partially hydrolyzed formula (pHF)

Standard formula (SF)

Arm Description

Infants fed exclusively with a infant formula based on partially hydrolyzed serum cow's milk proteins.

Infants fed exclusively with a standard formula based on intact cow's milk proteins

Outcomes

Primary Outcome Measures

Growth standard calculated z-scores
Using Z-scores including: weight (g), size (cm) and cranial perimeter (cm)
Symptoms associated with infant colic
Hours of crying, wakefulness, sleep for 24 hours, by adapting Barr's crying letter

Secondary Outcome Measures

Growth standard calculated z-scores
Using Z-scores including: weight (g), size (cm) and cranial perimeter (cm)
Gatrointestinal tolerance recording
Record in the patient's diary stool patterns (depositional rhythm and quality of faeces)
Infant illness and infection outcomes
Specific parent-reported infant symptoms (digestive, respiratory or other infections)
Behaviour/temperament test
Infant Behavior Questionnaire-Revised test: For this study, the very short form validated in Spanish that includes 37 items will be applied. Parents are asked to rate the frequency of specific, temperament-related behaviors observed during the last week.
Assessment of supplementary food
Investigator will collect data from the timetable for introduction of the different food groups
Food survey at the first year of life
Investigator will conduct a food consumption frequency survey
Product safety
Assessment of acceptance of the formula and record of potential adverse or side effects related to taking the product.

Full Information

First Posted
July 8, 2019
Last Updated
September 17, 2020
Sponsor
Laboratorios Ordesa
search

1. Study Identification

Unique Protocol Identification Number
NCT04015089
Brief Title
Infant Formula With Partially Hydrolyzed Cow's Milk Protein Versus a Formula With Intact Protein
Acronym
VEGY-UP
Official Title
Randomized, Parallel, Double-blind Study With a Partially Hydrolyzed Infant Formula With Cow's Milk Protein vs a Formula With Intact Protein to Assess Growth and Impact on the Gastrointestinal Manifestations of Colic in the Healthy Infant.
Study Type
Interventional

2. Study Status

Record Verification Date
September 2020
Overall Recruitment Status
Unknown status
Study Start Date
July 19, 2018 (Actual)
Primary Completion Date
December 2020 (Anticipated)
Study Completion Date
December 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Laboratorios Ordesa

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Randomized, parallel, double-blind clinical trial, comparing a partially hydrolyzed serum proteins infant formula with a conventional formula with intact protein in healthy infants that suffer from colic
Detailed Description
Demonstrate that an infant formula with partially hydrolized cow's milk protein of serum proteins is equivalent to an intact protein formula in healthy children in terms of safety of use and suitability, to prove that it can be a alternative with digestive health benefits in healthy children with infant colic.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infant Colic
Keywords
Infant formula, Partially hydrolized protein infant formula

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
156 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Partially hydrolyzed formula (pHF)
Arm Type
Experimental
Arm Description
Infants fed exclusively with a infant formula based on partially hydrolyzed serum cow's milk proteins.
Arm Title
Standard formula (SF)
Arm Type
Active Comparator
Arm Description
Infants fed exclusively with a standard formula based on intact cow's milk proteins
Intervention Type
Dietary Supplement
Intervention Name(s)
Partially hydrolyzed formula (pHF)
Intervention Description
Infant formula with partially hydrolyzed protein
Intervention Type
Dietary Supplement
Intervention Name(s)
Standard formula (SF)
Intervention Description
Infant formula with intact protein
Primary Outcome Measure Information:
Title
Growth standard calculated z-scores
Description
Using Z-scores including: weight (g), size (cm) and cranial perimeter (cm)
Time Frame
From baseline to 3 months after starting with the formula
Title
Symptoms associated with infant colic
Description
Hours of crying, wakefulness, sleep for 24 hours, by adapting Barr's crying letter
Time Frame
From baseline to 3 months after starting with the formula
Secondary Outcome Measure Information:
Title
Growth standard calculated z-scores
Description
Using Z-scores including: weight (g), size (cm) and cranial perimeter (cm)
Time Frame
At 6, 9 and 12 months old.
Title
Gatrointestinal tolerance recording
Description
Record in the patient's diary stool patterns (depositional rhythm and quality of faeces)
Time Frame
Baseline, 1, 2 and 3 months follow-up visit, and 6, 9 months old
Title
Infant illness and infection outcomes
Description
Specific parent-reported infant symptoms (digestive, respiratory or other infections)
Time Frame
Baseline, 1, 2 and 3 months follow-up visit, and 6, 9 months old
Title
Behaviour/temperament test
Description
Infant Behavior Questionnaire-Revised test: For this study, the very short form validated in Spanish that includes 37 items will be applied. Parents are asked to rate the frequency of specific, temperament-related behaviors observed during the last week.
Time Frame
1, 6, 12 months old
Title
Assessment of supplementary food
Description
Investigator will collect data from the timetable for introduction of the different food groups
Time Frame
At 6 and 9 months old
Title
Food survey at the first year of life
Description
Investigator will conduct a food consumption frequency survey
Time Frame
At 12 months old
Title
Product safety
Description
Assessment of acceptance of the formula and record of potential adverse or side effects related to taking the product.
Time Frame
At 1, 2 and 3 months follow-up visit, and 6, 9 months old

10. Eligibility

Sex
All
Minimum Age & Unit of Time
2 Weeks
Maximum Age & Unit of Time
8 Weeks
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Children diagnosed as nursing colic according to Roma IV criteria. Infants who have received breastfeeding at least 2 weeks. Infants who at the time of inclusion in the study whose parents/legal guardians voluntarily decide not to continue exclusive breastfeeding or only maintain it in residual form (less than 20% of the daily intake, one breast intake per day). Full-term infants (>37 weeks of gestation). Infants with weight suitable for their gestational age (2500-4500g). Normal APGAR score: 7-10. Infants between 2 and 8 weeks of life. Infants whose parents/legal guardians have signed informed consent. Infants with good availability of clinical follow-up until the end of the study. Exclusion Criteria: Infants fed from birth with exclusive infant formula. Infants with congenital diseases or malformations that may affect growth. Infants with major medical conditions that require chronic medication or close medical checks. Infants who have taken any type of antibiotics or probiotics prior to the study.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Roser De Castellar, MD
Phone
+34 902105243
Email
Roser.DeCastellar@ordesa.es
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Benjamin Martin Martínez
Organizational Affiliation
Consorci Sanitari de Terrassa
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Gemma Colomé Rivero
Organizational Affiliation
Fundació Hospital de Nens de Barcelona
Official's Role
Principal Investigator
Facility Information:
Facility Name
Consorci Sanitari de Terrassa
City
Terrassa
State/Province
Barcelona
ZIP/Postal Code
08227
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Benjamin Martin, MD
Phone
937310007
Email
bmartingastro@hotmail.com
Facility Name
Fundació Hospital de Nens
City
Barcelona
ZIP/Postal Code
08009
Country
Spain
Individual Site Status
Active, not recruiting

12. IPD Sharing Statement

Learn more about this trial

Infant Formula With Partially Hydrolyzed Cow's Milk Protein Versus a Formula With Intact Protein

We'll reach out to this number within 24 hrs